{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:54:01Z","timestamp":1790553241442,"version":"4.1.0"},"reference-count":27,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Early reports suggested that resistin is associated with obesity and insulin resistance in rodents. However, subsequent studies have not supported these findings. To our knowledge, the present study is the first assessment in human subjects of serum resistin and insulin sensitivity by the insulin clamp technique. Thirty-eight nonobese subjects [age, 23 \u00b1 4 yr; body mass index (BMI), 25.4 \u00b1 4.3 kg\/m2], 12 obese subjects (age, 54 \u00b1 8 yr; BMI, 33.0 \u00b1 2.5 kg\/m2), and 22 obese subjects with type 2 diabetes (age, 59 \u00b1 7 yr; BMI, 34.0 \u00b1 2.4 kg\/m2) were studied. Serum resistin concentrations were not different among nonobese (4.1 \u00b1 1.7 ng\/ml), obese (4.2 \u00b1 1.6 ng\/ml), and obese diabetic subjects (3.7 \u00b1 1.2 ng\/ml), and were not significantly correlated to glucose disposal rate during a hyperinsulinemic glucose clamp across groups. Serum resistin was, however, inversely related to insulin sensitivity in nonobese subjects only (r = \u22120.35; P = 0.05), although this association was lost after adjusting for percent body fat. Serum resistin was not related to percent fat, BMI, or fat cell size. A strong correlation was observed between serum resistin and resistin mRNA expression from abdominal sc adipose tissue in a separate group of obese subjects (r = 0.62; P &amp;lt; 0.01; n = 56). Although the exact function of resistin is unknown, we demonstrated only a weak relationship between resistin and insulin sensitivity in nonobese subjects, indicating that resistin is unlikely to be a major link between obesity and insulin resistance in humans.<\/jats:p>","DOI":"10.1210\/jc.2003-031410","type":"journal-article","created":{"date-parts":[[2004,4,7]],"date-time":"2004-04-07T22:23:39Z","timestamp":1081376619000},"page":"1844-1848","source":"Crossref","is-referenced-by-count":222,"title":["Relationship between Serum Resistin Concentrations and Insulin Resistance in Nonobese, Obese, and Obese Diabetic Subjects"],"prefix":"10.1210","volume":"89","author":[{"given":"L. K.","family":"Heilbronn","sequence":"first","affiliation":[{"name":"Pennington Biomedical Research Center (L.K.H., J.R., L.J., E.R., S.R.S.), Baton Rouge, Louisiana 70808"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rood","sequence":"additional","affiliation":[{"name":"Pennington Biomedical Research Center (L.K.H., J.R., L.J., E.R., S.R.S.), Baton Rouge, Louisiana 70808"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Janderova","sequence":"additional","affiliation":[{"name":"Pennington Biomedical Research Center (L.K.H., J.R., L.J., E.R., S.R.S.), Baton Rouge, Louisiana 70808"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. B.","family":"Albu","sequence":"additional","affiliation":[{"name":"Obesity Research Center, St. Luke\u2019s Roosevelt Hospital (J.B.A.), New York, New York 10025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. E.","family":"Kelley","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh (D.E.K.), Pittsburgh, Pennsylvania 15213"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ravussin","sequence":"additional","affiliation":[{"name":"Pennington Biomedical Research Center (L.K.H., J.R., L.J., E.R., S.R.S.), Baton Rouge, Louisiana 70808"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Smith","sequence":"additional","affiliation":[{"name":"Pennington Biomedical Research Center (L.K.H., J.R., L.J., E.R., S.R.S.), Baton Rouge, Louisiana 70808"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071618505862500_R1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00041433-200202000-00008","article-title":"Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin.","volume":"13","author":"Havel","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"2020071618505862500_R2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes.","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"2020071618505862500_R3","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1074\/jbc.C100028200","article-title":"A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation.","volume":"276","author":"Kim","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071618505862500_R4","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1093\/emboj\/19.15.4046","article-title":"FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family.","volume":"19","author":"Holcomb","year":"2000","journal-title":"EMBO J"},{"key":"2020071618505862500_R5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/79111","article-title":"Failure of adipocyte differentiation causes type II diabetes mellitus?","volume":"26","author":"Danforth","year":"2000","journal-title":"Nat Genet"},{"key":"2020071618505862500_R6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diabetes.51.1.7","article-title":"Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.","volume":"51","author":"McGarry","year":"2002","journal-title":"Diabetes"},{"key":"2020071618505862500_R7","doi-asserted-by":"crossref","first-page":"25651","DOI":"10.1074\/jbc.C100189200","article-title":"Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists.","volume":"276","author":"Way","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071618505862500_R8","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/oby.2002.149","article-title":"Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.","volume":"10","author":"Milan","year":"2002","journal-title":"Obes Res"},{"key":"2020071618505862500_R9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1172\/JCI16521","article-title":"Adipose-derived resistin and gut-derived resistin-like molecule-\u03b2 selectively impair insulin action on glucose production.","volume":"111","author":"Rajala","year":"2003","journal-title":"J Clin Invest"},{"key":"2020071618505862500_R10","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1006\/bbrc.2001.6132","article-title":"Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids.","volume":"289","author":"Juan","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071618505862500_R11","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1210\/jc.2002-021604","article-title":"Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.","volume":"88","author":"Yannakoulia","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618505862500_R12","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2003-030519","article-title":"Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects.","volume":"88","author":"Lee","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618505862500_R13","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2337\/diabetes.50.10.2199","article-title":"Resistin\/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.","volume":"50","author":"Savage","year":"2001","journal-title":"Diabetes"},{"key":"2020071618505862500_R14","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1210\/jcem.87.5.8627","article-title":"Increased resistin gene and protein expression in human abdominal adipose tissue.","volume":"87","author":"McTernan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618505862500_R15","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2337\/diabetes.52.7.1611","article-title":"A promoter genotype and oxidative stress potentially link resistin to human insulin resistance.","volume":"52","author":"Smith","year":"2003","journal-title":"Diabetes"},{"key":"2020071618505862500_R16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0197-2456(03)00064-3","article-title":"Look AHEAD: Action for Health in Diabetes. Design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.","volume":"24","author":"Look AHEAD Research Group: Ryan DH","year":"2003","journal-title":"Control Clin Trials"},{"key":"2020071618505862500_R17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/meta.2001.21693","article-title":"Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.","volume":"50","author":"Smith","year":"2001","journal-title":"Metabolism"},{"key":"2020071618505862500_R18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00075197-200209000-00005","article-title":"Measuring body fat distribution and content in humans.","volume":"5","author":"Goodpaster","year":"2002","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2020071618505862500_R19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0168-8278(97)80288-7","article-title":"Noninvasive in vivo quantitative assessment of fat content in human liver.","volume":"27","author":"Ricci","year":"1997","journal-title":"J Hepatol"},{"key":"2020071618505862500_R20","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1172\/JCI118637","article-title":"Early and late stimulation of ob mRNA expression in meal-fed and overfed rats.","volume":"97","author":"Harris","year":"1996","journal-title":"J Clin Invest"},{"key":"2020071618505862500_R21","first-page":"E106","article-title":"Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation","volume":"285","author":"Moon","year":"2003","journal-title":"Am J Physiol"},{"key":"2020071618505862500_R22","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s001250051560","article-title":"Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.","volume":"43","author":"Weyer","year":"2000","journal-title":"Diabetologia"},{"key":"2020071618505862500_R23","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diabetes.48.5.1113","article-title":"Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.","volume":"48","author":"Jacob","year":"1999","journal-title":"Diabetes"},{"key":"2020071618505862500_R24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2337\/diabetes.49.5.749","article-title":"Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.","volume":"49","author":"Ryysy","year":"2000","journal-title":"Diabetes"},{"key":"2020071618505862500_R25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(01)02968-4","article-title":"Inhibition by insulin of resistin gene expression in 3T3\u2013L1 adipocytes.","volume":"507","author":"Haugen","year":"2001","journal-title":"FEBS Lett"},{"key":"2020071618505862500_R26","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2337\/diabetes.50.10.2199","article-title":"Resistin Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-\u03b3 action in humans.","volume":"50","author":"Savage","year":"2001","journal-title":"Diabetes"},{"key":"2020071618505862500_R27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/bbrc.2001.5173","article-title":"Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle.","volume":"285","author":"Nagaev","year":"2001","journal-title":"Biochem Biophys Res Commun"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/89\/4\/1844\/10744088\/jcem1844.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/89\/4\/1844\/10744088\/jcem1844.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T04:05:42Z","timestamp":1594958742000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/89\/4\/1844\/2844543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,1]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2003-031410","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,1]]}}}